Viatris VTRS
NASDAQ VTRS
$16.08 -0.16 (-0.98%)
At close: Aug 20, 2026 · 1:03 PM UTC

Viatris (VTRS) Cash from Investing Activities Growth (3y) (2022 - 2026)

Viatris (VTRS) Cash from Investing Activities Growth (3y) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Haleon 43.92 Bn 42.96 Bn - -
2 Teva Pharmaceutical Industries 43.19 Bn 39.53 Bn 2.15 Bn -53.63%
3 Zoetis 31.74 Bn 30.06 Bn 1.05 Bn -55.36%
4 Takeda Pharmaceutical 28.67 Bn 22.87 Bn 5.10 Bn 34.35%
5 United Therapeutics 22.22 Bn 19.56 Bn 683.80 Mn 33.61%
6 Viatris 18.71 Bn 17.83 Bn 1.46 Bn 15.92%
7 Neurocrine Biosciences 15.55 Bn 15.16 Bn 935.80 Mn -2.45%
8 Elanco Animal Health 11.80 Bn 11.27 Bn 798.00 Mn -36.76%
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn - -
10 Alkermes 8.12 Bn 7.47 Bn 397.90 Mn -26.41%

Historic Data

Download Data
DateValue
Jun 30, 2026 15.92%
Mar 31, 2026 33.33%
Dec 31, 2025 -28.49%
Sep 30, 2025 4.90%
Jun 30, 2025 13.85%
Mar 31, 2025 0.91%
Dec 31, 2024 8.34%
Sep 30, 2024 156.05%
Jun 30, 2024 189.92%
Mar 31, 2024 -38.43%
Dec 31, 2023 47.32%
Mar 31, 2023 -72.66%
Dec 31, 2022 74.44%